Critical incidents related to opioid infusions in children: a five-year review and analysis

Nicholas West1, Vahid Nilforushan, Jonathan Stinson

  • 1Department of Anesthesiology, Pharmacology & Therapeutics, University of British Columbia, Vancouver, BC, Canada.

Insights

Critical incidents in pediatric opioid infusions were analyzed. Key causes included flawed order sheets and insufficient nursing guidelines for infusions and monitoring, impacting pediatric patient safety.

Area of Science:

  • Pediatric pharmacology
  • Patient safety research
  • Clinical incident analysis

Background:

  • Opioids carry significant risks due to their narrow therapeutic index.
  • Children, particularly infants, face heightened risks from opioid therapy due to developmental and pharmacogenetic factors.

Purpose of the Study:

  • To conduct a retrospective root cause analysis of critical incidents in children receiving opioid infusions.
  • To identify factors contributing to adverse events in pediatric opioid therapy.

Main Methods:

  • Reviewed patient safety and pharmacy data from 2004-2009.
  • Conducted a root cause analysis on incidents with a severity score ≥ 8.
  • Generated timelines and classified root causes for identified critical incidents.

Main Results:

  • 58 of 166 reviewed charts involved critical incidents, causing minor to moderate harm.
  • Analysis of 14 incidents revealed 31 root causes.
  • Frequent causes included pre-printed order sheet defects, lack of nursing guidelines for opioid infusions, and inadequate monitoring protocols.

Conclusions:

  • Identified root causes of critical incidents in pediatric opioid infusions.
  • Recommendations were developed to enhance patient safety and analgesia quality for children.
  • Findings inform improvements in clinical practice for pediatric pain management.
Abstract

Related Concept Videos

Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
116
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
1.0K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
967
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
408
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
554
Pharmaceutical Poisoning: Treatment Strategies01:26

Pharmaceutical Poisoning: Treatment Strategies

Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...
279